Pharmaceutical Profits Exposed

Brigham reveals the stark realities of drug pricing, highlighting how pharmacy benefit managers profit significantly while patients face steep copays. He discusses the disparity between the actual costs paid by insurers and the inflated prices presented to consumers, particularly with tier four drugs like GLP-1s. Additionally, he shares his experience with the challenges faced by small pharmacies when dealing with large insurance companies.